4 documents

Read All
13:50 , Jan 29, 2019 |  BC Innovations  |  Distillery Techniques

Assays and screens

TECHNOLOGY: Diagnostic assays; binding assays A peptide cleavage-based assay for detecting B. anthracis lethal factor could enable rapid diagnosis of anthrax infection. The micro-plate based assay involves detecting B. anthracis lethal factor by co-incubating plasma...
Read More
07:00 , Aug 16, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Anthrax Bacillus anthracis lethal factor In vitro studies suggest depsidones could help treat anthrax exposure. A high throughput screen for compounds that inhibit the...
Read More
08:00 , Feb 28, 2011 |  BC Week In Review  |  Clinical News

Dual Antibody Approach: Phase I started

IQ began a double-blind, placebo-controlled, dose-escalation Phase I trial to evaluate IQ-DAA in up to 32 healthy volunteers. IQ Therapeutics B.V. , Groningen, the Netherlands   Product: Dual Antibody Approach ( IQ-DAA )   Business:...
Read More
07:00 , Jul 29, 2002 |  BC Week In Review  |  Company News

University of Padova other research news

Researchers published in Nature a method for assaying LF metalloproteolytic activity using peptide substrates. The researchers suggested that these substrates could be used for high throughput screening of chemical libraries to identify specific LF inhibitors....
Read More